These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Bacterial β-Glucosidase Reveals the Structural and Functional Basis of Genetic Defects in Human Glucocerebrosidase 2 (GBA2). Charoenwattanasatien R; Pengthaisong S; Breen I; Mutoh R; Sansenya S; Hua Y; Tankrathok A; Wu L; Songsiriritthigul C; Tanaka H; Williams SJ; Davies GJ; Kurisu G; Cairns JR ACS Chem Biol; 2016 Jul; 11(7):1891-900. PubMed ID: 27115290 [TBL] [Abstract][Full Text] [Related]
46. Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases. Bouscary A; Quessada C; René F; Spedding M; Henriques A; Ngo S; Loeffler JP Eur J Pharmacol; 2020 Oct; 884():173446. PubMed ID: 32739173 [TBL] [Abstract][Full Text] [Related]
47. Current and Novel Aspects on the Non-lysosomal β-Glucosylceramidase GBA2. Massimo A; Maura S; Nicoletta L; Giulia M; Valentina M; Elena C; Alessandro P; Rosaria B; Sandro S Neurochem Res; 2016 Feb; 41(1-2):210-20. PubMed ID: 26603294 [TBL] [Abstract][Full Text] [Related]
48. Biochemical Characterization of the Malekkou A; Samarani M; Drousiotou A; Votsi C; Sonnino S; Pantzaris M; Chiricozzi E; Zamba-Papanicolaou E; Aureli M; Loberto N; Christodoulou K Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30308956 [TBL] [Abstract][Full Text] [Related]
49. Glycomimetics at the mirror: medicinal chemistry of L-iminosugars. D'Alonzo D; Guaragna A; Palumbo G Curr Med Chem; 2009; 16(4):473-505. PubMed ID: 19199917 [TBL] [Abstract][Full Text] [Related]
50. Synthesis of tricyclic benzimidazole-iminosugars as potential glycosidase inhibitors via a Mitsunobu reaction. Yan L; Lui H; Sun J; Gao L; Lu X; Li X; Chen H Carbohydr Res; 2019 Nov; 485():107807. PubMed ID: 31520817 [TBL] [Abstract][Full Text] [Related]
51. Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C mice. Nietupski JB; Pacheco JJ; Chuang WL; Maratea K; Li L; Foley J; Ashe KM; Cooper CG; Aerts JM; Copeland DP; Scheule RK; Cheng SH; Marshall J Mol Genet Metab; 2012 Apr; 105(4):621-8. PubMed ID: 22366055 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and evaluation of hydroxymethylaminocyclitols as glycosidase inhibitors. Trapero A; Egido-Gabás M; Bujons J; Llebaria A J Org Chem; 2015 Apr; 80(7):3512-29. PubMed ID: 25750987 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of nonnatural L-iminosugar C,C-glycosides, a new class of C-branched iminosugars, as glycosidase inhibitors. Désiré J; Debbah Z; Gueyrard D; Marrot J; Blériot Y; Kato A Carbohydr Res; 2023 Oct; 532():108903. PubMed ID: 37523839 [TBL] [Abstract][Full Text] [Related]
55. A new archaeal beta-glycosidase from Sulfolobus solfataricus: seeding a novel retaining beta-glycan-specific glycoside hydrolase family along with the human non-lysosomal glucosylceramidase GBA2. Cobucci-Ponzano B; Aurilia V; Riccio G; Henrissat B; Coutinho PM; Strazzulli A; Padula A; Corsaro MM; Pieretti G; Pocsfalvi G; Fiume I; Cannio R; Rossi M; Moracci M J Biol Chem; 2010 Jul; 285(27):20691-703. PubMed ID: 20427274 [TBL] [Abstract][Full Text] [Related]
56. Beta-D-glycosylamidines: potent, selective, and easily accessible 1-glycosidase inhibitors. Guo W; Hiratake J; Ogawa K; Yamamoto M; Ma SJ; Sakata K Bioorg Med Chem Lett; 2001 Feb; 11(4):467-70. PubMed ID: 11229749 [TBL] [Abstract][Full Text] [Related]
57. Characterization of the Zebrafish Homolog of β-Glucosidase 2: A Target of the Drug Miglustat. Sultana S; Truong NY; Vieira DB; Wigger JG; Forrester AM; Veinotte CJ; Berman JN; van der Spoel AC Zebrafish; 2016 Jun; 13(3):177-87. PubMed ID: 26909767 [TBL] [Abstract][Full Text] [Related]
59. Decreased expression of GBA3 correlates with a poor prognosis in hepatocellular carcinoma patients. Ying JF; Zhang YN; Song SS; Hu ZM; He XL; Pan HY; Zhang CW; Wang HJ; Li WF; Mou XZ Neoplasma; 2020 Sep; 67(5):1139-1145. PubMed ID: 32412773 [TBL] [Abstract][Full Text] [Related]
60. Glucosylceramide mimics: highly potent GCase inhibitors and selective pharmacological chaperones for mutations associated with types 1 and 2 Gaucher disease. Schönemann W; Gallienne E; Ikeda-Obatake K; Asano N; Nakagawa S; Kato A; Adachi I; Górecki M; Frelek J; Martin OR ChemMedChem; 2013 Nov; 8(11):1805-17. PubMed ID: 24115322 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]